| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 4e-06 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 2e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |